An Italian multicenter, retrospective observational study evaluating efficacy and tolerability of Perampanel (PER) in children and adolescents with refractory epilepsies in daily clinical practice conditions.
Phase of Trial: Phase IV
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 06 Feb 2017 New trial record